Treatment of patients with cocaine-induced arrhythmias: Bringing the bench to the bedside

British Journal of Clinical Pharmacology

Volumn 69, Issue 5, 2010, Pages 448-457

  Hoffman, Robert S ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY POISON CONTROL CENTER   (United States)

Author keywords

Arrhythmia; Cocaine; Ion channel blockade; Therapy

Indexed keywords

BENZODIAZEPINE; BICARBONATE; CATECHOLAMINE; COCAINE; DIAZEPINE DERIVATIVE; DILTIAZEM; LIDOCAINE; LORAZEPAM; MIDAZOLAM; NIFEDIPINE; PHENTOLAMINE; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ACTION POTENTIAL; ACUTE CORONARY SYNDROME; BRUGADA SYNDROME; COOLING; CORONARY ARTERY CONSTRICTION; DRUG INDUCED DISEASE; DRUG USE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERKALEMIA; NONHUMAN; OXYGEN THERAPY; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; R WAVE; RESTLESSNESS; RESUSCITATION; REVIEW; SEDATION; SINUS TACHYCARDIA; T WAVE;

ANIMALS; ARRHYTHMIAS, CARDIAC; CATECHOLAMINES; COCAINE; COCAINE-RELATED DISORDERS; DOGS; DOPAMINE UPTAKE INHIBITORS; HUMANS; ION CHANNELS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RABBITS;

EID: 77950674436     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03632.x     Document Type: Review

References (70)

1. Wood DM, Dargan PI. Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective. Br J Clin Pharmacol 2010 69 : 443 447.
2. Mittleman RE, Wetli CV. Cocaine and sudden 'natural' death. J Forensic Sci 1987 32 : 11 9.
3. Mehta A, Jain AC, Mehta MC. Electrocardiographic effects of intravenous cocaine: an experimental study in a canine model. J Cardiovasc Pharmacol 2003 41 : 25 30.
4. O'Leary ME, Hancox JC. Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated arrhythmias. Br J Clin Pharmacol 2010 69 : 427 442.
5. Macedo T, Ribeiro CA, Cotrim D, Tavares P, Morgadinho MT, Caramona M, Vicente MT, Rodrigues L, Cardoso MG, Keating ML. Catecholamine and MHPG plasma levels, platelet MAO activity, and 3H-imipramine binding in heroin and cocaine addicts. Mol Neurobiol 1995 11 : 21 9.
6. Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med 1992 10 : 169 177.
7. Hollander JE, Hoffman RS, Burstein JL, Shih RD, Thode HC Jr. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med 1995 155 : 1081 1086.
8. Nelson LS. Toxicologic myocardial sensitization. J Toxicol Clin Toxicol 2002 40 : 867 879.
9. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984 24 : 129 147.
10. Starmer CF, Grant AO, Strauss HC. Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 1984 46 : 15 27.
11. Wang RY. pH-dependent cocaine-induced cardiotoxicity. Am J Emerg Med 1999 17 : 364 369.
12. Niemann JT, Bessen HA, Rothstein RJ, Laks MM. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986 57 : 1154 1159.
13. Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991 83 : 1649 1659.
14. Chakko S, Sepulveda S, Kessler KM, Sotomayor MC, Mash DC, Prineas RJ, Myerburg RJ. Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse). Am J Cardiol 1994 74 : 710 713.
15. Littmann L, Monroe MH, Svenson RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc 2000 75 : 845 849.
16. Bebarta VS, Summers S. Brugada electrocardiographic pattern induced by cocaine toxicity. Ann Emerg Med 2007 49 : 827 829.
17. Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. J Electrocardiol 2001 34 : 345 349.
18. Schwartz AB, Janzen D, Jones RT, Boyle W. Electrocardiographic and hemodynamic effects of intravenous cocaine in awake and anesthetized dogs. J Electrocardiol 1989 22 : 159 166.
19. Beckman KJ, Parker RB, Hariman RJ, Gallastegui JL, Javaid JI, Bauman JL. Hemodynamic and electrophysiological actions of cocaine. Effects of sodium bicarbonate as an antidote in dogs. Circulation 1991 83 : 1799 1807.
20. Winecoff AP, Hariman RJ, Grawe JJ, Wang Y, Bauman JL. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1. Comparison with sodium bicarbonate and quinidine. Pharmacotherapy 1994 14 : 698 703.
21. Whitcomb DC, Gilliam FR III., Starmer CF, Grant AO. Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine. J Clin Invest 1989 84 : 1629 1636.
22. Dolara P, Franconi F. Hypertonic sodium chloride and lidocaine in a case of imipramine intoxication. Clin Toxicol 1977 10 : 395 398.
23. Jensen AM. Amitriptyline poisoning with severe cardiac arrhythmia treated with lidocaine. Ugeskr Laeger 1970 132 : 98 100.
24. Kerns W II., Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med 1997 15 : 321 329.
25. Jonsson S, O'Meara M, Young JB. Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med 1983 75 : 1061 1064.
26. Derlet RW, Albertson TE, Tharratt RS. Lidocaine potentiation of cocaine toxicity. Ann Emerg Med 1991 20 : 135 138.
27. Heit J, Hoffman RS, Goldfrank LR. The effects of lidocaine pretreatment on cocaine neurotoxicity and lethality in mice. Acad Emerg Med 1994 1 : 438 442.
28. Grawe JJ, Hariman RJ, Winecoff AP, Fischer JH, Bauman JL. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 2. Concentration-effect relationships. Pharmacotherapy 1994 14 : 704 711.
29. Shih RD, Hollander JE, Burstein JL, Nelson LS, Hoffman RS, Quick AM. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med 1995 26 : 702 706.
30. Smilkstein MJ. Reviewing cyclic antidepressant cardiotoxicity: wheat and chaff. J Emerg Med 1990 8 : 645 648.
31. Parker RB, Perry GY, Horan LG, Flowers NC. Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram. J Cardiovasc Pharmacol 1999 34 : 864 869.
32. DeWitt CR, Cleveland N, Dart RC, Heard K. The effect of amiodarone pretreatment on survival of mice with cocaine toxicity. J Med Toxicol 2005 1 : 11 8.
33. Baumann BM, Perrone J, Hornig SE, Shofer FS, Hollander JE. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med 2000 7 : 878 885.
34. Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes (see comment). Am J Emerg Med 2003 21 : 39 42.
35. Albertson TE, Dawson A, de Latorre F, Hoffman RS, Hollander JE, Jaeger A, Kerns WR 2nd., Martin TG, Ross MP, American Heart Association, International Liaison Committee on Resuscitation. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001 4 (Suppl. S78 90.
36. Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008 51 : 127 129.
37. Kimura S, Bassett AL, Xi H, Myerburg RJ. Early afterdepolarizations and triggered activity induced by cocaine. A possible mechanism of cocaine arrhythmogenesis. Circulation 1992 85 : 2227 2235.
38. Gamouras GA, Monir G, Plunkitt K, Gursoy S, Dreifus LS. Cocaine abuse: repolarization abnormalities and ventricular arrhythmias. Am J Med Sci 2000 320 : 9 12.
39. Singh N, Singh HK, Singh PP, Khan IA. Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome. Am J Ther 2001 8 : 299 302.
40. Schrem SS, Belsky P, Schwartzman D, Slater W. Cocaine-induced torsades de pointes in a patient with the idiopathic long QT syndrome. Am Heart J 1990 120 : 980 984.
41. Riaz K, McCullough PA. Fatal case of delayed repolarization due to cocaine abuse and global ischemia. Rev Cardiovasc Med 2003 4 : 47 53.
42. Perera R, Kraebber A, Schwartz MJ. Prolonged QT interval and cocaine use. J Electrocardiol 1997 30 : 337 339.
43. Krantz MJ, Rowan SB, Mehler PS. Cocaine-related torsade de pointes in a methadone maintenance patient. J Addict Dis 2005 24 : 53 60.
44. Taylor D, Parish D, Thompson L, Cavaliere M. Cocaine induced prolongation of the QT interval. Emerg Med J 2004 21 : 252 253.
45. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007 100 : 609 615.
46. Nahas GG, Trouve R, Manger WM. Cocaine, catecholamines and cardiac toxicity. Acta Anaesthesiol Scand Suppl 1990 94 : 77 81.
47. Trouve R, Nahas GG, Manger WM. Catecholamines, cocaine toxicity, and their antidotes in the rat. Proc Soc Exp Biol Med 1991 196 : 184 187.
48. Sloan MA, Mattioni TA. Concurrent myocardial and cerebral infarctions after intranasal cocaine use. Stroke 1992 23 : 427 430.
49. Merigian KS. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporally related to naloxone administration. Am J Emerg Med 1993 11 : 96 7.
50. Greenblatt DJ, Ehrenberg BL, Gunderman J, Scavone JM, Tai NT, Harmatz JS, Shader RI. Kinetic and dynamic study of intravenous lorazepam: comparison with intravenous diazepam. J Pharmacol Exp Ther 1989 250 : 134 140.
51. Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989 45 : 356 365.
52. Greenblatt DJ, Joyce TH, Comer WH, Knowles JA, Shader RI, Kyriakopoulos AA, MacLaughlin DS, Ruelius HW. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection. Clin Pharmacol Ther 1977 21 : 222 230.
53. Wermeling DP, Miller JL, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol 2001 41 : 1225 1231.
54. Hung OR, Dyck JB, Varvel J, Shafer SL, Stanski DR. Comparative absorption kinetics of intramuscular midazolam and diazepam. Can J Anaesth 1996 43 (5 Pt 1 450 455.
55. Watson DM, Uden DL. Promotion of intramuscular diazepam questioned. Am J Hosp Pharm 1981 38 : 968, 970 971.
56. Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg 1983 62 : 1 8.
57. Guinn MM, Bedford JA, Wilson MC. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol 1980 16 : 499 508.
58. Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther 1981 217 : 350 356.
59. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, Bedotto JB, Danziger RS, Hillis LD. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990 112 : 897 903.
60. Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 1991 9 : 161 163.
61. Fareed FN, Chan G, Hoffman RS. Death temporally related to the use of a beta adrenergic receptor antagonist in cocaine associated myocardial infarction. J Med Toxicol 2007 3 : 169 172.
62. McCord J, Jneid H, Hollander JE, de Lemos JA, Cercek B, Hsue P, Gibler WB, Ohman EM, Drew B, Philippides G, Newby LK, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008 117 : 1897 1907.
63. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995 333 : 1267 1272.
64. Isner JM, Estes NA III., Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, Katsas G, Sweeney K, Sturner WQ. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986 315 : 1438 1443.
65. Billman GE. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation. J Pharmacol Exp Ther 1993 266 : 407 416.
66. Billman GE, Hoskins RS. Cocaine-induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil. FASEB J 1988 2 : 2990 2995.
67. Billman GE. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate. J Pharmacol Exp Ther 1994 269 : 409 416.
68. Lange RA, Cigarroa RG, Yancy CW Jr., Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989 321 : 1557 1562.
69. Chan GM, Sharma R, Price D, Hoffman RS, Nelson LS. Phentolamine therapy for cocaine- association acute coronary syndrome (CAACS). J Med Toxicol 2006 2 : 108 111.
70. Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med 1992 327 : 361.